Wallace Y. Langdon

11.6k total citations · 2 hit papers
122 papers, 9.2k citations indexed

About

Wallace Y. Langdon is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Wallace Y. Langdon has authored 122 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 42 papers in Immunology and 24 papers in Oncology. Recurrent topics in Wallace Y. Langdon's work include Ubiquitin and proteasome pathways (20 papers), T-cell and B-cell Immunology (19 papers) and Protein Kinase Regulation and GTPase Signaling (16 papers). Wallace Y. Langdon is often cited by papers focused on Ubiquitin and proteasome pathways (20 papers), T-cell and B-cell Immunology (19 papers) and Protein Kinase Regulation and GTPase Signaling (16 papers). Wallace Y. Langdon collaborates with scholars based in Australia, United States and China. Wallace Y. Langdon's co-authors include Christine B.F. Thien, Herbert C. Morse, Jerry M. Adams, Hamid Band, Ivan Đikić, David D.L. Bowtell, Christopher E. Andoniou, Suzanne Cory, Timothy J. Blake and Iwona Szymkiewicz and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Wallace Y. Langdon

120 papers receiving 9.1k citations

Hit Papers

c-Cbl/Sli-1 regulates end... 1998 2026 2007 2016 1998 2001 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wallace Y. Langdon 5.9k 2.7k 2.4k 1.3k 1.0k 122 9.2k
Robert Rottapel 4.0k 0.7× 3.7k 1.3× 2.5k 1.0× 858 0.7× 766 0.8× 134 8.2k
Keith C. Robbins 5.1k 0.9× 1.6k 0.6× 1.8k 0.8× 896 0.7× 620 0.6× 94 8.1k
Jacalyn H. Pierce 6.2k 1.1× 3.4k 1.2× 4.0k 1.7× 743 0.6× 646 0.6× 128 11.5k
Larry R. Rohrschneider 4.3k 0.7× 2.0k 0.7× 1.4k 0.6× 997 0.8× 521 0.5× 100 6.9k
Thomas O. Daniel 4.6k 0.8× 1.2k 0.5× 1.4k 0.6× 966 0.7× 1.0k 1.0× 58 7.2k
Andrew F. Wilks 4.8k 0.8× 2.8k 1.0× 4.5k 1.9× 673 0.5× 472 0.5× 101 9.0k
Yuji Yamanashi 3.5k 0.6× 2.3k 0.8× 1.2k 0.5× 817 0.6× 322 0.3× 94 7.1k
Norman N. Iscove 4.5k 0.8× 3.1k 1.1× 1.7k 0.7× 638 0.5× 2.4k 2.3× 76 9.1k
David T. Weaver 6.5k 1.1× 1.4k 0.5× 2.6k 1.1× 747 0.6× 336 0.3× 150 9.0k
André Veillette 5.7k 1.0× 9.9k 3.6× 3.5k 1.4× 716 0.5× 1.1k 1.1× 182 14.7k

Countries citing papers authored by Wallace Y. Langdon

Since Specialization
Citations

This map shows the geographic impact of Wallace Y. Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wallace Y. Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wallace Y. Langdon more than expected).

Fields of papers citing papers by Wallace Y. Langdon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wallace Y. Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wallace Y. Langdon. The network helps show where Wallace Y. Langdon may publish in the future.

Co-authorship network of co-authors of Wallace Y. Langdon

This figure shows the co-authorship network connecting the top 25 collaborators of Wallace Y. Langdon. A scholar is included among the top collaborators of Wallace Y. Langdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wallace Y. Langdon. Wallace Y. Langdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Rong, Wallace Y. Langdon, & Jian Zhang. (2022). Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases. Frontiers in Endocrinology. 13. 971162–971162. 22 indexed citations
2.
Tang, Rong, Wallace Y. Langdon, & Jian Zhang. (2018). Regulation of immune responses by E3 ubiquitin ligase Cbl-b. Cellular Immunology. 340. 103878–103878. 58 indexed citations
3.
Taylor, Samuel J., et al.. (2016). Dasatinib promotes the activation of quiescent hematopoietic stem cells in mice. Experimental Hematology. 44(5). 410–421.e5. 8 indexed citations
4.
Rathinam, Chozhavendan, Christine B.F. Thien, Richard A. Flavell, & Wallace Y. Langdon. (2010). Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling. Cancer Cell. 18(4). 341–352. 74 indexed citations
5.
Thien, Christine B.F., James H. Steer, Frank Köentgen, et al.. (2010). c-Cbl Promotes T Cell Receptor-induced Thymocyte Apoptosis by Activating the Phosphatidylinositol 3-Kinase/Akt Pathway. Journal of Biological Chemistry. 285(14). 10969–10981. 19 indexed citations
6.
Mamchak, Alusha A., Christine B.F. Thien, Julia Lyandres, et al.. (2009). Unaltered negative selection and Treg development of self‐reactive thymocytes in TCR transgenic Fyn‐deficient mice. European Journal of Immunology. 40(2). 539–547. 2 indexed citations
7.
Rathinam, Chozhavendan, Christine B.F. Thien, Wallace Y. Langdon, Hua Gu, & Richard A. Flavell. (2008). The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells. Genes & Development. 22(8). 992–997. 83 indexed citations
8.
Gustin, Sonja E., Christine B.F. Thien, & Wallace Y. Langdon. (2006). Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells. The Journal of Immunology. 177(9). 5980–5989. 31 indexed citations
9.
Gaston, Isabelle, Kara Johnson, Tsukasa Oda, et al.. (2004). Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl. Experimental Hematology. 32(1). 113–121. 7 indexed citations
10.
Oksvold, Morten P., Henrik S. Huitfeldt, & Wallace Y. Langdon. (2004). Identification of 14‐3‐3ζ as an EGF receptor interacting protein. FEBS Letters. 569(1-3). 207–210. 43 indexed citations
11.
Scaife, Robin M., Didier Job, & Wallace Y. Langdon. (2003). Rapid Microtubule-dependent Induction of Neurite-like Extensions in NIH 3T3 Fibroblasts by Inhibition of ROCK and Cbl. Molecular Biology of the Cell. 14(11). 4605–4617. 26 indexed citations
12.
Thien, Christine B.F., Francesca Walker, & Wallace Y. Langdon. (2001). RING Finger Mutations that Abolish c-Cbl-Directed Polyubiquitination and Downregulation of the EGF Receptor Are Insufficient for Cell Transformation. Molecular Cell. 7(2). 355–365. 145 indexed citations
13.
Peschard, Pascal, Tanya M. Fournier, Louie Lamorte, et al.. (2001). Mutation of the c-Cbl TKB Domain Binding Site on the Met Receptor Tyrosine Kinase Converts It into a Transforming Protein. Molecular Cell. 8(5). 995–1004. 346 indexed citations
14.
Kirsch, Kathrin H., Maria-Magdalena Georgescu, Tomoyuki Shishido, et al.. (2001). The Adapter Type Protein CMS/CD2AP Binds to the Proto-oncogenic Protein c-Cbl through a Tyrosine Phosphorylation-regulated Src Homology 3 Domain Interaction. Journal of Biological Chemistry. 276(7). 4957–4963. 74 indexed citations
15.
Fournier, Tanya M., Louie Lamorte, Christiane R. Maroun, et al.. (2000). Cbl-transforming Variants Trigger a Cascade of Molecular Alterations That Lead to Epithelial Mesenchymal Conversion. Molecular Biology of the Cell. 11(10). 3397–3410. 30 indexed citations
16.
Lupher, Mark, Kris A. Reedquist, Sachiko Miyake, Wallace Y. Langdon, & Hamid Band. (1996). A Novel Phosphotyrosine-binding Domain in the N-terminal Transforming Region of Cbl Interacts Directly and Selectively with ZAP-70 in T Cells. Journal of Biological Chemistry. 271(39). 24063–24068. 179 indexed citations
17.
Langdon, Wallace Y.. (1995). The cbl oncogene: a novel substrate of protein tyrosine kinases. Australian and New Zealand Journal of Medicine. 25(6). 859–864. 33 indexed citations
18.
Harris, A. W., Carl A. Pinkert, M Crawford, et al.. (1988). The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.. The Journal of Experimental Medicine. 167(2). 353–371. 346 indexed citations
19.
Morse, Herbert C., George F. Tidmarsh, Kevin L. Holmes, et al.. (1987). Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc.. The Journal of Experimental Medicine. 165(3). 920–925. 11 indexed citations
20.
Morse, Herbert C., J B Roths, Wendy F. Davidson, et al.. (1985). Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr.. The Journal of Experimental Medicine. 161(3). 602–616. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026